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Introduction 
 
Menière’s disease was first described by Pros-
per Menière in 1861 [1] and comprises the 
symptom triad of recurrent, spontaneous ver-
tigo, sensorineural hearing loss and tinnitus. 
Vertigo attacks are often accompanied by nau-
sea and vomiting. Defective hearing often fluc-
tuates at the beginning of the disease and nor-
malizes in the attack free intervals. During the 
following course of disease hearing loss persists 
commonly in the low frequencies. The most in-
criminating symptom for patients is usually ver-
tigo [2].  
 
The pathophysiologic mechanism for Menière’s 
disease is an endolymphatic hydrops caused by 
disorders of the endolymph production or re-
sorption. In consequence, the Reissner`s mem-
brane ruptures [3,4] and K+ leaks from the en-
dolymphatic into the perilymphatic space caus-
ing a non-physiological activation of vestibular 
nerve fibres with the symptom vertigo [5]. Rup-
ture of Reissner’s membrane in the apex of the 
cochlea leads to hearing loss in the lower fre-
quency range [6]. 
 
Therapy of Menière’s disease varies stepwise 
from conservative medical treatment to radical 
surgical procedures [7,8].  
 
An innovation in treatment was the application 
of ototoxic aminoglycosides in 1957 by Schuk-
necht [9]. By inducing a pharmacological 
neurectomy, the symptoms of Menière’s dis-
ease could be influenced beneficially. Subse-
quently, it was shown that a low dose intratym-
panal application of gentamicin was sufficient 
to achieve relief for the patients, without de-
stroying the complete vestibular system [10-
13]. Many studies have dealt with aminoglyco-
sides and have suggested an effect not only on 
hair cells but also on the stria vascularis, mar-
ginal cells, fibrocytes [14-20] or vestibular dark 
cells [21]. However, in these studies high con-
centrations of gentamicin were applied, which 
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destroyed not only hair cells but also a lot of 
other cell types in the inner ear.  
 
Until now, the target cells for low dose gen-
tamicin therapy that convey the relief from 
Menière symptoms still remain unclear. It is the 
aim of the present study to identify the target 
cells in the inner ear of the rat by using short 
time exposure- and low-dose application of gen-
tamicin. 
 
Materials and methods  
 
Animals 
 
Young, 2-4 month old rats were obtained from 
the breeding colony of the animal facilities at 
the medical faculty of the University of Regens-
burg. Two offspring of black hooded (BDE) rats 
initially obtained from Boehringer Ingelheim and 
three offspring of the ACI strain from Harlan-
Winkelmann of either sex were used in the pre-
sent experiments. The use of animals in this 
study complies with the current „German Law 
on the Protection of Animals“ (Tierschutzgesetz 
§4 Satz 3). 
 
Gentamicin 
 
Texas red conjugated gentamicin has been 
used to analyze aminoglycoside uptake in the 
inner ear [e.g. 41]. The pattern of fluorescence 
induced by exposure to Texas Red conjugated 
gentamicin in the inner ear was similar to that 
determined by immunohistochemical analysis 
following exposure to native gentamicin [e.g. 
46]. In the present study we used Texas Red 
conjugated gentamicin to analyze the pattern of 
fluorescence in defined cochlear and vestibular 
structures following a short exposure of the 
acutely isolated rat cochlea (for details see be-
low). This degree of fluorescence is interpreted 
as an indicator of the gentamicin concentration 
in the respective cochlear and vestibular re-
gions and is referred to as gentamicin fluores-
cence.  
 
A stock solution of Texas Red conjugated gen-
tamicin was prepared according to Lyford-Pike 
et al. [36]. First gentamicin sulfate (Sigma, Cat. 
# G1264) was dissolved in 0.1M potassium 
carbonate solution (K2CO3, Sigma, Cat. # 
P5833) with pH 9 at a concentration of 50 mg/
ml. Then Texas Red-X succinimidyl ester 
(Invitrogen Cat. # T6134) was dissolved in NN-
dimethylformamide (Sigma, Cat. # D4254) at a 
concentration of 2 mg/ml. For conjugation, 0.5 
ml of the Texas Red solution and 3.67 ml of the 
gentamicin solution were mixed and stored un-
der agitation on a shaker in a cold room until 
used (at least 24 hours). This stock solution 
contains 44 mg gentamicin per ml and was di-
luted to the desired concentrations of 500, 
1250 and 2500 µg/ml in Dulbecco’s Modified 
Eagle Medium (DMEM with 4mM l-glutamine, 
1000mg/l d-glucose and 110 mg/l sodium py-
ruvate; Invitrogen Cat. # 31885023). For control 
experiments 0.5 ml of the Texas Red solution 
was combined with 3.67 ml 0.1M potassium 
carbonate solution without gentamicin and ade-
quate aliquots were added to DMEM for expo-
sure in control experiments. In 3 experiments 
we used the lowest concentration of 500 µg/ml 
and additional experiments were performed 
using 1250 and 2500 µg/ml, respectively.  
 
Preparation 
 
In order to isolate the temporal bones, the rats 
were killed by decapitation with a guillotine. 
Then the skull was opened dorsally and the 
brain partially removed. The tympanic bullae 
were exposed and the left and right side sepa-
rated from the skull and placed separately into 
petri dishes filled with cold DMEM. Access to 
the inner ear was achieved by opening the bul-
lae with blunt forceps. Excess tissue and bony 
structures were carefully removed. With the 
help of a small metal hook the stapes was re-
moved from the oval window, the round window 
was ruptured and small perforations were made 
into the bony wall at the level of the scala tym-
pani of the cochlear base and at the apex of the 
cochlea. The isolated inner ear was then trans-
ferred to fresh DMEM in a 24-well tissue culture 
plate and cleaned from blood by carefully flush-
ing DMEM through the perilymphatic space with 
a fine-tipped pipette at the exposed oval and 
round windows and the apical opening. It was 
then transferred to the next well with the incu-
bation solution that was again gently flushed 
through the perilymphatic spaces by a fine 
tipped pipette. The preparation of both ears 
until exposure to the incubation solution was 
typically achieved within 7-12 minutes. In each 
experiment one ear was exposed to gentamicin 
while the other served as control. In two 500 
µg/ml experiments control ears were incubated 
in pure DMEM without any addition while in the 
3 other experiments corresponding amounts of 
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Texas Red solution without gentamicin in DMEM 
were used for incubation.  
 
Exposure 
 
The inner ears were incubated for 10 minutes 
and then transferred to DMEM. Excess incuba-
tion solution was flushed out of the perilym-
phatic spaces with a fine tipped pipette and the 
inner ears were transferred to 4% paraformalde-
hyde in 0.1M phosphate buffer with pH 7.6 for 
fixation. Fixation in the paraformaldehyde solu-
tion was performed for 90 minutes. The solution 
was changed 3 times during this period and 
gently flushed through the perilymphatic spaces 
every 15 minutes to achieve a good fixation. 
The tissue was then transferred to 0.3% Triton 
X100 (Sigma, Cat. # X100) in 0.1M phosphate 
buffer for 90 minutes to make the cell mem-
branes permeable for a subsequent actin label 
with fluorescein-conjugated phalloidin. The tis-
sue was transferred to the fluorescein phal-
loidin (Invitrogen, Cat. # F432) staining solution 
(20 µl stock solution prepared according to the 
manufacturer’s instructions were diluted in 1 ml 
0.1 M PBS with 0.3 % Triton). Incubation lasted 
90 minutes in the phalloidin solution with a gen-
tle flushing of the perilymphatic spaces every 
15 minutes. Following the actin staining, the 
cochleae were washed and perilymphatic 
spaces flushed with decalcification solution (4 
% paraformaldehyde, 0.1 M EDTA in 0.1 M 
phosphate buffer). Each ear was placed in a 50 
ml falcon tube with decalcification solution on a 
shaker in the cold room at 4°C. The solution 
was changed every 2-3 days. After a decalcifica-
tion period of 10 days the cochleae were 
washed in phosphate buffer and placed in 30% 
saccharose solution under agitation at 4°C 
overnight for cryoprotection of the tissue. Prop-
erly oriented 10 µm thick frozen sections of the 
inner ear were collected on slides, dried and 
covered slipped with Vectashield with DAPI 
(Linaris, Cat. # H-1200) in order to stain nuclei. 
Using this procedure the binding or accumula-
tion of gentamicin was indicated by the Texas 
Red fluorescence while the actin staining due to 
the green fluorescein and the nuclear staining 
due to the blue DAPI fluorescence provided ori-
entation and landmarks in these sections of the 
inner ear.  
 
Analysis 
 
The sections were examined under a Leica DM 
RBE microscope (Leica Mikrosysteme, Ben-
sheim, Germany) with epifluorescence. Images 
were digitized with a Spot RT3 Slider camera 
(Diagnostic instruments, Stirling Heights, Mich., 
USA) with the help of VisiView (Visitron Systems 
GmbH Puchheim, Germany). To achieve high 
sensitivity and resolution we used a 40x lens 
resulting in a nominal resolution of 0.19 µm per 
pixel. For each frame, separate images were 
digitized with the Texas Red, the fluorescein and 
the DAPI fluorescence filters. The exposure time 
for each channel was determined in pilot experi-
ments (2 s for Texas Red and fluorescein, 0.1 s 
for DAPI) and subsequently kept constant for 
digitizing all images with a 16 bit gray level 
depth. Further processing of the raw images 
was done using ImageJ 1.43. For each image 
we performed a background subtraction with 
the dark background option selected and a roll-
ing ball radius of 50 pixels. The settings for opti-
mizing brightness and contrast for each channel 
were also determined in pilot experiments and 
subsequently used for all images (Texas Red: 
min 80, max 350; fluorescein: min 40, max 
1500; DAPI: min 100, max 1500). Following 
these processing steps, images were converted 
to 8 bit gray level depth and the red, green and 
blue image of each frame combined to a RGB 
image. To obtain overviews of a section through 
the cochlea including the spiral ganglion, organ 
of Corti, stria vascularis and the spiral ligament 
or covering complete sections through the vesti-
bular organs, several overlapping frames were 
taken and subsequently assembled to an over-
view with high resolution using Photoshop CS4 
(Figure 2, 3, 4, 5). These overviews were used 
for a qualitative visual evaluation of gentamicin 
accumulation in the inner ear.  
 
For a quantitative analysis of Texas Red fluores-
cence as an indicator of gentamicin distribution 
in the tissue we defined 11 distinct areas in the 
overviews of cochlear sections and 10 distinct 
areas in overviews of sections through vestibu-
lar organs (Figure 1, Table 1). Using ImageJ 
1.43 the regions of interest representing the 
above defined cochlear or vestibular areas were 
selected in the overviews using the polygon se-
lection tool and the mean gray level of the red 
channel in each region of interest was calcu-
lated.  
 
The software PASW statistics 17 (SPSS Inc.) 
was used for calculating the test statistics. First, 
data from each of the 11 cochlear and 10 vesti-
bular areas were assigned to one of 6 groups: 
1) treated with 500 µg/ml gentamicin, 2) con-
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trol in the 500 µg/ml experiment, 3) treated 
with 1250 µg/ml gentamicin, 4) control in the 
1250 µg/ml experiment, 5) treated with 2500 
µg/ml gentamicin, 6) control in the 2500 µg/ml 
experiment. For each area a Kruskal Wallis test 
was performed comparing these 6 groups to 
determine if gray levels differed significantly 
between groups. Since these tests revealed a 
significant effect of group for each of the 21 
areas (p ≤ 0.011) subsequent pair wise com-
parisons with Mann Whitney U tests were per-
formed. To identify areas where gray values 
were significantly elevated in the gentamicin 
treated ears compared to the corresponding 
controls comparisons were performed within 
each of the 3 gentamicin doses (500 µg/ml: 
group 1 versus group 2; 1250 µg/ml: group 3 
versus group 4; 2500 µg/ml: group 5 versus 
group 6). To identify dose dependent effects of 
gentamicin, pair wise comparisons within each 
area were performed comparing gray levels in 
ears treated with 500 and 1250 µg/ml (group 1 
Figure 1, A-D: Schematic illustration of sections showing the cochlea (A), saccule (B), utricle (C) and ampule (D). 1 = 
inner hair cells, 2 = outer hair cells, 3 = lower spiral limbus, 4 = interdental cells, 5 = dendrites of spiral ganglion 
cells, 6 = inner sulcus cells, 7 = dorsal spiral ligament, 8 = ventral spiral ligament, 9 = stria vascularis, 10 = spiral 
ganglion, 11 Hensen / Claudius cells, 12 = saccule hair/supporting cells, 13 = saccule transitional cells, 14 = sac-
cule nerve fiber region, 15 = utricle hair/supporting cells, 16 = utricle transitional cells, 17 = utricle nerve fiber re-
gion, 18 = ampule hair/supporting cells, 19 = ampule transitional cells, 20 = ampule nerve fiber region, 21 = dark 
cells.  
Table 1. Analyzed structures   
Cochlea Vestibular  organ 
1 =  Inner hair cell 12 = Saccule hair cells and supporting cells 
2 = Outer hair cells 13 = Saccule transitional cells 
3 = Spiral limbus below interdental cells 14 = Saccule nerve fiber region 
4 = Interdental cells 15 = Utricle hair cells and supporting cells 
5 = Nerve fiber bundle in the region of the Spiral lamina 16 = Utricle transitional cells 
6 = Inner sulcus cells 17 = Utricle nerve fiber region 
7 = Dorsal spiral ligament 18 = Ampule hair cells and supporting cells 
8 = Ventral spiral ligament 19 = Ampule transitional cells 
9 = Stria vascularis 20 = Ampule nerve fiber region 
10 = Spiral ganglion 21 = Dark cells 
11 = Hensen / Claudius cells   
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versus group 3), 1250 and 2500 µg/ml (group 
3 versus group 5) and 500 and 2500 µg/ml 
group 1 versus group 5). A corresponding analy-
sis was performed between the controls (group 
2 versus group 4, group 4 versus group 6 and 
group 2 versus group 6) to identify a potential 
non specific binding of the Texas Red control 
solution without gentamicin.  
 
Results 
 
Qualitative analysis 
 
We started with a qualitative analysis of Texas 
red conjugated gentamicin binding by visual 
inspection of the sections through the cochlea 
and the vestibular regions.  
Cochlear structures 
 
Visual inspection of the sections exposed to a 
concentration of 500 µg/ml gentamicin showed 
elevated gentamicin fluorescence in non-
cellular structures such as the basilar mem-
brane, the lining of the perilymphatic spaces 
and the osseous spiral lamina compared to con-
trol sections as illustrated in the overviews 
shown in Figure 2. For better orientation, the 
images in Figure 2A (exposed to 500 µg/ml gen-
tamicin) and Figure 2B (control) show compos-
ite images of the three colour channels demon-
strating gentamicin fluorescence in red, actin 
labelling by phalloidin in green and nuclear 
staining by DAPI in blue. In these composite 
RGB images different cochlear structures can 
Figure 2. Overview of a section through the cochlea exposed to 500 µg/ml gentamicin (A,C) and a corresponding con-
trol exposed only to DMEM (B,D). Figures A and B show composite RGB images of the three colour channels repre-
senting Texas Red coupled gentamicin (red), FITC-phalloidin labelled actin (green) and DAPI stained nuclei (blue) and 
allow a clear identification of the different cochlear structures (e.g. spiral limbus, SL; basilar membrane, BM; Organ of 
Corti, OC). Only the corresponding images of the red colour channel are shown in Figure 2C,D and emphasize the 
distinct and elevated red fluorescence in the section from a cochlea exposed to 500 µg/ml gentamicin (Figure 2C) as 
compared to the low degree of background fluorescence in a control (Figure 2D). The labels and arrows pointing to 
OC, SL and BM in the images of the red channel (Figure 2C,D) resemble those from the composite images (Figure 
2A,B). The scale bar in the bottom right of Fig. 2B indicates 500 µm. 
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be clearly recognized as shown by the labels 
and arrows pointing to the Organ of Corti (OC), 
the spiral limbus (SL) and the basilar membrane 
(BM). To emphasize the difference in the pat-
tern of red fluorescence between gentamicn 
exposed and control ears only the correspondig 
red channel is shown in Figure 2C and Figure 
2D respectively. While some unspecific red fluo-
rescence is visible in the region of the spiral 
ganglion and the stria vascularis in the control 
(Figure 2B,D), most other cochlear regions were 
devoid of visual red fluorescence. Figure 2D 
illustrates that the Organ of Corti (OC), the spiral 
ligament (SL) and the basilar membrane (BM) 
cannot be recognized and defined in the image 
of the red channel despite the arrows that point 
to the identical positions illustrated in the com-
posite image (Figure 2B). Thus, due to the low 
background fluorescence of the red channel 
(e.g. Figure 2D), composite images were neces-
sary to unequivocally identify the cochlear and 
vestibular regions defined in Figure 1 for subse-
quent quantitative measurements.  
 
With respect to cellular structures, red fluores-
cence of gentamicin was seen in some interden-
tal cells of the spiral limbus (Figure 2A) and in a 
few inner hair cells. This is illustrated at higher 
magnification in Figure 3 with red fluorescence 
visible in a population of interdental cells 
(Figure 3 A-D) and some inner hair cells (Figure 
3 C,D). The examples from controls (Figure 3 
E,F) demonstrate the specificity of gentamicin 
fluorescence shown in Figure 3 A-D.  
 
In the outer hair cells no gentamicin fluores-
Figure 3. High magnification views of a cochlear sections exposed to 500 µg/ml gentamicin (A-D) and controls (E,F). 
Texas red conjugated gentamicin is visible as red fluorescence, cell nuclei are shown in blue and actin is shown by 
the green fluorescence. The scale bar in the bottom right of Fig. 3F indicates 100 µm. 
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cence could be detected visually (Figure 3A-D) 
at a gentamicin concentration of 500 µg/ml. 
The visual interpretation of the red fluorescence 
in the cells of the spiral ganglion, between the 
basal and the marginal cells of the stria vascu-
laris and the ventral spiral ligament was ham-
pered by background fluorescence in controls 
(e.g. Figure 2B).  
 
At higher drug concentrations of 1250 (Figure 
4A) and 2500 µg/ml (Figure 4C), gentamicin 
fluorescence appeared much more widespread 
in the cochlea, especially, inner as well as outer 
hair cells, inner sulcus cells, interdental cells, 
fibrocytes of the spiral limbus, the spiral gan-
glion, stria vascularis, the ventral spiral ligament 
and also non-cellular structures like the basilar 
membrane, osseous spiral lamina, the lining of 
the perilymphatic spaces and the tectorial mem-
brane showed a clear gentamicin fluorescence 
(Figure 4A,C). The specificity of gentamicin fluo-
rescence is illustrated by the corresponding 
controls shown in the right column of Figure 4 
(B,D). The images in Figure 4 A, C  demonstrate 
a more intense red gentamicin fluorescence 
signal  as compared to the corresponding con-
trols shown in Figure 4 B, D. 
Vestibular structures 
 
Following an exposure with 500 µg/ml gen-
tamicin no specific gentamicin fluorescence 
was seen in vestibular structures while at higher 
concentrations gentamicin fluorescence be-
came visible. This is exemplified in Figure 5 for 
the saccule. The left column shows sections 
from inner ears exposed to 500 (Figure 5A), 
1250 (Figure 5C) and 2500 µg/ml (Figure 5E) 
while corresponding controls are shown in the 
right column. Over all, gentamicin fluorescence 
in vestibular structures appeared lower com-
pared to the cochlea (compare Figure 3-5).  
 
Over all, the qualitative visual analysis of the 
sections indicated only for cochlear interdental 
and inner hair cells specific gentamicin fluores-
cence at the lowest gentamicin concentration 
tested (500 µg/ml). At the higher concentra-
tions visual assessment suggested more pro-
nounced gentamicin fluorescence in cochlear 
compared to vestibular structures (Figure 3-5).  
 
In addition to this qualitative visual evaluation 
of gentamicin fluorescence we performed a 
quantitative gray level analysis of the red fluo-
Figure 4. High magnification views of cochlear sections exposed to 1250 µg/ml gentamicin (A) and 2500 µg/ml gen-
tamicin (C) and corresponding controls (B,D). Texas red conjugated gentamicin is visible as red fluorescence, cell 
nuclei are shown in blue and actin is shown by the green fluorescence. The scale bar in the bottom right of Fig. 3F 
indicates 100 µm.  
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rescence for the cochlear and vestibular regions 
defined in Figure 1 and listed in Table 1.  
 
Quantitative analysis 
 
Over all conditions, 1126 gray level measure-
ments were obtained from cochlear areas and 
396 from vestibular areas. The majority of 
measurements was collected for the 500 µg/ml 
concentration of gentamicin (cochlear 705; ves-
tibular 207) since we were primarily interested 
in the uptake following exposure to a low dose 
of gentamicin.  
 
The gray level is a quantitative measure of the 
fluorescence signal. Low gray levels are associ-
ated with a weak fluorescence and high num-
bers are associated with a high fluorescence.  
Cochlear structures  
 
Figure 6 compares mean gray level and stan-
dard deviation obtained in eleven cochlear re-
gions in controls (white bars) and following gen-
tamicin exposure at a concentration of 500µg/
ml (filled black bars). Because in controls and in 
samples exposed to 500 µg/ml the red fluores-
cence signal was typically low (Figure 2) the gray 
levels are shown on a logarithmic scale to em-
phasize potential small differences. For most 
cochlear structures the background fluores-
cence in controls was low (below 10), only the 
ventral spiral ligament (mean 13), stria vascu-
laris (mean 42), the spiral ganglion (mean 32) 
and the Hensen/Claudius cells (mean 14) 
showed a higher degree of background fluores-
cence (see also background fluorescence in Fig. 
Figure 5. Sections through the saccule exposed to 500 µg/ml gentamicin (A), 1250 µg/ml gentamicin (C) and 2500 
µg/ml gentamicin (E) and corresponding controls (B,D,F). Texas red conjugated gentamicin  is shown as red fluores-
cence, cell nuclei are shown in blue and actin is shown by the green fluorescence. The scale bar in the bottom right of 
Figure 5F indicates 100 µm.  
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2B,D, 4B,D). Although visual inspection of the 
images revealed only some interdental and 
some inner hair cells that ap-
peared red following gentamicin 
treatment, the quantitative 
analysis presented in Fig. 6 indi-
cates that red fluorescence fol-
lowing 500µg/ml gentamicin 
treatment significantly exceeded 
background fluorescence of con-
trols in inner hair cells, outer hair 
cells, lower spiral limbus, inter-
dental cells, dendrites of the 
spiral ganglion, inner sulcus cells 
and the dorsal spiral ligament. 
For the ventral spiral ligament, 
the stria vascularis, the spiral 
ganglion and the Hensen / 
Claudius cells there was no sig-
nificant difference between con-
trols and sections from inner 
ears exposed to 500µg/ml gen-
tamicin.  
 
At a gentamicin concentration of 
1250 µg/ml fluorescence in ex-
posed inner ears was generally 
higher compared to 500 µg/ml. 
In inner ears exposed to 1250 
µg/ml gentamicin gray levels 
exceeding a value of 100 were 
found in outer hair cells, the stria 
vascularis and the spiral gan-
glion. Gray levels in the range 50
-100 were found for inner hair 
cells, interdental cells and for 
the dendrites of the spiral gan-
glion. The lowest mean gray level 
of 9 was found for inner sulcus 
cells but this was considerably 
higher than the mean gray level 
of 2 in inner sulcus cells of con-
trols. Compared to controls, all 
cochlear structures except for 
the Hensen / Claudius cells 
showed a significantly elevated 
fluorescence signal following 
1250 µg/ml gentamicin expo-
sure.  
 
At a gentamicin concentration of 
2500 µg/ml the fluorescence 
signal was significantly elevated 
compared to background fluo-
rescence in controls for all 11 
cochlear regions analyzed (Figure 7). With the 
exception of inner sulcus cells, the dorsal and 
Figure 6. Comparison of the gray levels in controls (white bars) and gen-
tamicin exposed (black bars) cochlear regions for the 500 µg/ml condi-
tion. A significant difference in gray level between exposed cochleae and 
controls is indicated by a star. Note the logarithmic gray level scale to 
visualize small differences. This quantitative analysis revealed that expo-
sure to 500µg/ml gentamicin was associated with a significantly higher 
fluorescence in seven of the eleven analyzed cochlear structures as com-
pared to background fluorescence in controls. 1 = inner hair cells, 2 = 
outer hair cells, 3 = lower spiral limbus, 4 = interdental cells, 5 = den-
drites of spiral ganglion cells, 6 = inner sulcus cells, 7 = dorsal spiral 
ligament, 8 = ventral spiral ligament, 9 = stria vascularis, 10 = spiral 
ganglion, 11 = Hensen / Claudius cells. 
 
Figure 7. Comparison of controls (white bars) and gentamicin exposed 
(black bars) cochlear regions for the 2500 µg/ml condition. Significantly 
elevated gentamicin fluorescence in comparison to controls is indicated 
by a star. At this high gentamicin concentration all examined cochlear 
structures showed a significant elevation of gentamicin fluorescence  
above background in controls. 1 = inner hair cells, 2 = outer hair cells, 3 
= lower spiral limbus, 4 = interdental cells, 5 = dendrites of spiral gan-
glion cells, 6 = inner sulcus cells, 7 = dorsal spiral ligament, 8 = ventral 
spiral ligament, 9 = stria vascularis, 10 = spiral ganglion, 11 = Hensen / 
Claudius cells. 
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ventral spiral ligament and the Hensen / 
Claudius cells mean gray level exceeded a value 
of 100, representing a bright fluorescence. The 
data in Figure 7 show that the fluorescence in 
controls was low.  
 
The results show a dose dependent variation of 
gentamicin fluorescence in cochlear structures, 
higher concentrations of gentamicin were asso-
ciated with a higher fluorescence signal. This 
was confirmed by a statistical analysis. Pair 
wise comparisons (Mann Whitney U tests) re-
vealed that rising gentamicin concentration 
from 500 µg/ml to 1250 µg/ml led to a signifi-
cant increase of fluorescence (and conse-
quantly gentamicin binding) in all 11 cochlear 
structures analyzed (p < 0.001).  
 
Increasing the gentamicin dose further from 
1250 to 2500 µg/ml was associated with a sig-
nificantly increasing fluorescence in inner hair 
cells, spiral limbus, interdental cells, the den-
drites of the cochlear ganglion cells, inner sul-
cus and dorsal spiral ligament (p ≤ 0.022), dem-
onstrating a systematic dose dependent in-
crease of gentamicin fluorescence in these co-
chlear structures for gentamicin concentrations 
varying between 500 and 2500 µg/ml. In outer 
hair cells, the ventral spiral ligament, the stria 
vascularis, the spiral ganglion and the Hensen / 
Claudius cells no significant increase of fluores-
cence was found for increasing 
gentamicin concentration from 
1250 to 2500 µg/ml (p > 0.05) 
suggesting that gentamicin con-
centration in the tissue may be 
saturated by doses below 2500 
µg/ml in these cochlear struc-
tures.  
 
The variation of background fluo-
rescence between the different 
cochlear regions in controls 
(Figure 6, 7) complicates the di-
rect comparison of gentamicin 
fluorescence.  
 
To minimize the contribution of 
background fluorescence in con-
trols for the evaluation of gen-
tamicin fluorescence, we sub-
tracted the gray level obtained in 
controls from the value obtained 
in gentamicin treated inner ears. 
Figure 8 compares the difference 
obtained at the three gentamicin 
concentrations (500 µg/ml: white bars; 1250 
µg/ml gray bars; 2500 µg/ml: black bars) for 
the cochlea. Data are only shown when the dif-
ference between control and exposed tissue 
was significant. This analysis confirms that the 
highest dose dependent increase of gentamicin 
fluorescence preferentially occurs in cochlear 
regions closer to the modiolus (inner and outer 
hair cells, spiral limbus including interdental 
cells and the dendrites of the spiral ganglion) 
while gentamicin fluorescence appeared less 
pronounced in the dorsal and ventral spiral liga-
ment, the stria vascularis and the cochlear gan-
glion. Although the inner sulcus cells showed 
over all a very limited gentamicin fluorescence, 
fluorescence was significant higher in the ex-
posed as compared to the control at 500 µg/ml 
and fluorescence increased systematically by 
increasing the gentamicin dose to 1250 and 
2500 µg/ml. The data in Fig. 8 demonstrate a 
differential, region specific and dose dependent 
degree of gentamicin fluorescence in the coch-
lea.  
 
Vestibular structures 
 
Mean gray levels obtained with exposure to 500 
µg/ml gentamicin (black bars) and correspond-
ing controls (white bars) are shown in Figure 9 
for vestibular structures. This comparison dem-
onstrates only for the hair cell / supporting cell 
Figure 8. Comparison of gray levels exceeding significantly background 
fluorescence in corresponding controls for the three gentamicin concen-
trations (500, 1250, 2500 µg/ml) tested in eleven cochlear structures. 
Shown is the difference of the gray level in gentamicin exposed regions 
and corresponding controls. White bars represent exposure to 500 mg/
ml gentamicin, grey bars represent 1250 µg/ml gentamicin and black 
bars represent 2500 µg/ml gentamicin. 1 = inner hair cells, 2 = outer 
hair cells, 3 = lower spiral limbus, 4 = interdental cells, 5 = dendrites of 
spiral ganglion cells, 6 = inner sulcus cells, 7 = dorsal spiral ligament, 8 
= ventral spiral ligament, 9 = stria vascularis, 10 = spiral ganglion, 11 = 
Hensen / Claudius cells. 
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and the transitional cell region of the saccule an 
obvious increase of fluorescence above back-
ground. The statistical analysis confirmed that 
this increased fluorescence was significant (p ≤ 
0.004; indicated by the asterisk in Figure 9). All 
other vestibular structures (utricle, ampule and 
dark cells) did not show a significant increase of 
gentamicin fluorescence above background.  
 
At a gentamicin concentration of 1250 µg/ml all 
vestibular regions except the regions of saccular 
afferent dendrites and the utricular transitional 
cells showed significantly elevated fluorescence 
compared to controls (p ≤ 0.025).  
 
The mean gray levels obtained in the vestibular 
regions at a gentamicin dose of 2500 µg/ml are 
shown in Fig. 10. Compared to the cochlea 
(Figure 7) the gentamicin fluorescence at a 
dose of 2500 µg/ml appeared less pronounced 
in the vestibular regions. For each vestibular 
region, the mean gray value in the presence of 
gentamicin was elevated compared to controls. 
However, most likely due to the limited sample 
size, this difference was not significant for the 
transitional cells and the region of afferent den-
drites of the utricle (3 exposed versus 5 con-
trols) and the ampullar transitional cells (6 ex-
posed versus 2 controls).  
Comparing the mean gray 
levels following 500 µg/ml 
with those following 2500 
µg/ml revealed a significant 
increasing fluorescence in all 
vestibular structures (p ≤ 
0.024) except for the region 
of saccular afferent den-
drites. Increasing the gen-
tamicin dose from 1250 to 
2500 µg/ml was only associ-
ated with a significant in-
crease of the gray level (p = 
0.025) for the region of 
utricular afferent dendrites. 
In most vestibular regions, 
significant gentamicin fluo-
rescence compared to con-
trols was found at a concen-
tration of 1250 µg/ml and 
further increasing the dose of 
gentamicin was not associ-
ated with increased fluores-
cence.  
 
The difference of gray levels 
in the presence of gentamicin and the corre-
sponding controls is shown in Figure 11 for the 
vestibular region. Compared to the cochlea 
(Figure 8) the increase of fluorescence above 
control levels is on average lower in the vestibu-
lar regions. In contrast to a number of cochlear 
regions a systematic dose dependent increase 
of gentamicin from 500 to 2500 µg/ml was not 
seen in the vestibular system. Significant gen-
tamicin fluorescence above background in con-
trols at 500 µg/ml was only seen in the hair 
cells /supporting cells and the transitional cells 
of the saccule.  
 
In conclusion, a 10 minute exposure of the 
freshly isolated rat cochlea to gentamicin is as-
sociated with more pronounced gentamicin fluo-
rescence in the cochlea as compared to vestibu-
lar organs (see Figure 3-5). At the lowest dose 
tested (500 µg/ml) significantly elevated gen-
tamicin fluorescence above background in con-
trols was observed in 7 of the eleven analyzed 
cochlear structures (Figure 6), but only in 2 of 
the 10 vestibular structures (Figure 9). A sys-
tematically increasing gentamicin fluorescence 
for doses from 500 to 2500 µg/ml was found in 
7 cochlear structures (Figure 8) but not in the 
vestibule (Figure 11). Thus, under these experi-
mental conditions, gentamicin fluorescence is 
Figure 9. Comparison of controls (white bars) and gentamicin exposed 
(black bars) vestibular regions for the 500 µg/ml condition. A significant 
difference of gentamicin fluorescence between exposed and control con-
ditions is indicated by the star. Note the logarithmic gray level scale to 
visualize small differences. Only the hair cells / supporting cells and the 
transitional cell region of the saccule showed a specific gentamicin fluo-
rescence above background fluorescence in controls. 12 = saccule hair/
supporting cells, 13 = saccule transitional cells, 14 = saccule nerve fiber 
region, 15 = utricle hair/supporting cells, 16 = utricle transitional cells, 17 
= utricle nerve fiber region, 18 = ampule hair/supporting cells, 19 = 
ampule transitional cells, 20 = ampule nerve fiber region, 21 = dark cells. 
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higher in the cochlea and lower in vestibular 
organs.  
 
Discussion 
 
The isolated cochlea preparation 
 
In the present study we analyzed gentamicin 
fluorescence in a freshly isolated cochlea prepa-
ration following a 10 minute gentamicin expo-
sure. The physiological state of the isolated 
cochlea differs from the situation in vivo. The 
disruption of blood and oxygen supply is associ-
ated with a very fast decline of the endococh-
lear potential [22,23] leading to a decreased 
gain of the cochlear amplifier [24] that will af-
fect hair cell transduction [25,26]. In addition 
immersing the isolated cochlea in the cold incu-
bation solution will reduce over all metabolic 
activity.  
 
Although the physiological state of the isolated 
cochlea differs from the in vivo situation, iso-
lated cochlea preparations have been useful for 
studying different aspects of cochlear function 
[e.g. 27,28,29,30,31,32]. The advantage of the 
isolated preparation with perfusion of gen-
tamicin solution through the scalae is that co-
chlear and vestibular structures are rapidly ex-
posed to a well defined concentration of gen-
tamicin. Over all, the pattern of 
gentamicin fluorescence that 
we found in the cochlear and 
vestibular structures analyzed 
shows many parallels and simi-
larities with other published 
data (for details see discussion 
below) suggesting that the iso-
lated cochlea is in general use-
ful for analyzing the distribution 
of gentamicin in the inner ear. 
For the stria vascularis Wang 
and Steyger [46] reported 
prominent gentamicin fluores-
cence following intraperitoneal 
application in the mouse that 
differs from the moderate gen-
tamicin fluorescence that we 
observed in the stria vascularis 
following gentamicin exposure 
of the isolated rat cochlea. 
While gentamicin applied sys-
temically by intraperitoneal in-
jection enters the cochlea 
through the vasculature of the 
stria vascularis [46], gen-
tamicin reaches cochlear structures without 
passage through the stria vascularis by perfu-
sion of the cochlear scalae (like in the present 
experiments) or by intratympanal application 
(that is used clinically). Thus different forms of 
gentamicin application could explain the differ-
ent pattern of gentamicin fluorescence in the 
stria vascularis. An additional potential differ-
ence to other published data may be related to 
the uptake in hair cells. Most other studies re-
port the most prominent presence of gen-
tamicin in inner and outer hair cells [e.g. 19] 
while our qualitative observations found visible 
gentamicin fluorescence only in interdental cells 
and some inner but not in outer hair cells (Fig. 
3) at the lowest 500 µg/ml concentration. We 
suggest that the loss of EP in the isolated coch-
lea affects gentamicin accumulation in hair cells 
compared to the in vivo situation.  
 
In summary, interpretation of the present find-
ings in comparison with other studies needs to 
consider the physiological status in the isolated 
preparation as well as other methodological 
aspects outlined above. Bearing this in mind our 
analysis provides a quantitative description of 
the distribution of gentamicin fluorescence that 
is in most aspects consistent with previous 
qualitative descriptions of the location of gen-
tamicin in the inner ear. Our data allow direct 
Figure 10. Comparison of controls (white bars) and gentamicin exposed 
(black bars) vestibular regions for the 2500 µg/ml condition. Significantly 
elevated gentamicin fluorescence in comparison to controls is indicated 
by a star. Significant elevation of gentamicin fluorescence above back-
ground in corresponding controls was found in seven of the ten examined 
vestibular structures. Compared to the cochlea (Figure 7) gentamicin fluo-
rescence appeared less pronounced in vestibular structures. 12 = saccule 
hair/supporting cells, 13 = saccule transitional cells, 14 = saccule nerve 
fiber region, 15 = utricle hair/supporting cells, 16 = utricle transitional 
cells, 17 = utricle nerve fiber region, 18 = ampule hair/supporting cells, 
19 = ampule transitional cells, 20 = ampule nerve fiber region, 21 = dark 
cells. 
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comparisons of gentamicin fluorescence for 
distinct cochlear and vestibular regions (see 
Figure 6-11). 
 
Concentration of gentamicin 
 
An innovation in the therapy of Menière`s dis-
ease was the local intratympanal application of 
ototoxic streptomycin in 1957 [9]. The rationale 
behind this strategy was the aim of a chemical 
destruction of vestibular hair cells. A severe and 
undesired side effect was the associated 
cochleotoxicity. Based on experience with pa-
tients treated between 1967 – 1977 with intra-
tympanic aminoglycosides [33] the focus of 
therapy shifted from destroying vestibular hair 
cells to interfering with the secretory epithelium 
involved in inner ear ion homeostasis, and con-
sequently avoiding hair cell loss and cochleotox-
icity. This work formed the basis for the empiri-
cal establishment of low dose gentamicin ther-
apy that allows sufficient control of Menière 
attacks without destroying the complete vesti-
bular system and preserving hearing 
[10,34,11,12,13]. Typically 10-40 mg/ml gen-
tamicin were applied intratympanally [35,13]. 
Despite successful clinical use of low dose gen-
tamicin therapy the detailed mechanisms of 
action and the targets of gentamicin within the 
inner ear are not fully under-
stood. The present study tried 
to attempt to identify the cells 
of the inner ear that accumu-
late gentamicin within a short 
period following exposure.  
 
Aminoglycosides have a vari-
ety of adverse effects on the 
inner ear, such as inducing 
apoptosis in cochlear and 
vestibular hair cells [36, 37, 
38, 9]. High concentrations of 
40 mg/ml gentamicin applied 
via an osmotic pump into the 
perilymphatic space resulted 
in a reduction of function of 
the cochlear and vestibular 
organs in guinea pigs, 
whereas lower concentra-
tions (4 mg/ml gentamicin) 
did not [40]. 
 
Most studies have examined 
the changes of cochlear and 
vestibular structures follow-
ing longer time periods (up to months) and 
higher gentamicin concentrations in comparison 
to our experiments [compare 41, 42, 43, 19, 
44, 40]. We were interested in identifying those 
cells and structures within the cochlea and the 
vestibular organs that show elevated concentra-
tions of gentamicin (as indicated by a higher 
degree of fluorescence) following acute expo-
sure to the lower range of concentrations 
reached in the inner ear following intratympanic 
administration of therapeutic doses.  
 
Plontke et al. developed models for the predic-
tion of gentamicin gradients in the inner ear of 
chinchilla and guinea pig following intratym-
panal application [45,43]. Their model predicts 
a high concentration at the base of the cochlea 
(in the range of 16% of the intratympanal con-
centration) that rapidly declines towards the 
apex reaching 1-3 % of the applied intratym-
panal concentration in the apical half of the 
cochlea (see Figure 7 in Plontke et al., 2007 
[43]). The concentration of gentamicin solution 
applied intratympanally for the therapy of 
Menière`s disease is typically 40 mg/ml [e.g. 
13]. Based on the Plontke model, we chose to 
expose the freshly isolated inner ears in the 
present experiments to gentamicin concentra-
tions of 500, 1250 and 2500 µg/ml because 
Figure 11. Comparison of gray levels exceeding background fluorescence 
in corresponding controls for the three gentamicin concentrations (500, 
1250, 2500 µg/ml) tested in 10 vestibular structures. Shown is the differ-
ence of the gray level in gentamicin exposed regions and corresponding 
controls. White bars represent exposure to 500 mg/ml gentamicin, grey 
bars represent 1250 µg/ml gentamicin and black bars represent 2500 
µg/ml gentamicin. 12 = saccule hair/supporting cells, 13 = saccule transi-
tional cells, 14 = saccule nerve fiber region, 15 = utricle hair/supporting 
cells, 16 = utricle transitional cells, 17 = utricle nerve fiber region, 18 = 
ampule hair/supporting cells, 19 = ampule transitional cells, 20 = ampule 
nerve fiber region, 21 = dark cells. 
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these concentrations correspond to 1-6% of the 
intratympanally applied 40 mg/ml solution used 
for the clinical treatment of Menière`s disease 
[e.g. 13].  
 
Accumulation of gentamicin in the inner ear 
 
A number of studies have analyzed the accumu-
lation of gentamicin in the cochlea in some de-
tail [19,42,46]. Comparable data with respect 
to the vestibular system are not very detailed 
[19,42] or restricted to specific end organs 
[47,48]. A direct comparison of previously pub-
lished data with our present findings is compli-
cated by methodological differences; however, a 
number of similarities as well as discrepancies 
can be identified.  
 
A comparison of Figure 6 - 8 representing the 
cochlea with Figure 9 -11 representing the vesti-
bular organs illustrates a more pronounced gen-
tamicin fluorescence in some cochlear as com-
pared to the vestibular regions analyzed in the 
present study.  
 
Within the cochlea gentamicin fluorescence at 
the lowest dose analyzed (500 µg/ml, Figure 6) 
was significantly above background fluores-
cence predominantly in regions closer to the 
medial portion of the cochlea (both hair cells 
types, the spiral limbus including interdental 
cells, the dendrites of the spiral ganglion cells, 
and the inner sulcus cells). On the lateral side of 
the hair cells only the region of the dorsal spiral 
ligament showed significantly elevated gen-
tamicin fluorescence above background. The 
stria vacularis, the ventral spiral ligament, the 
Hensen / Claudius cell region and the spiral 
ganglion did not show significant elevation of 
gentamicin fluorescence at this low dose. At the 
highest gentamicin dose tested (2500µg/ml) all 
cochlear structures showed elevated gen-
tamicin fluorescence (Figure 7). The most pro-
nounced systematic dose dependent increase 
of gentamicin fluorescence was present in both 
types of hair cells, the spiral limbus including 
interdental cells and the dendrites of the audi-
tory nerve fibers (Figure 8).  
 
In the vestibular system we found a significant 
elevation of gentamicin fluorescence only for 
the saccular hair cells and transitional cells at 
500 µg/ml (Figure 9). Gentamicin fluorescence 
increased with increasing dose (Figure 10), 
however, compared to the cochlea the degree 
of fluorescence appeared more limited 
(compare Figure 11 with Figure 8).  
 
Our results are in many aspects consistent with 
previous reports. A comparison of our data col-
lected after a 10 minute exposure of the inner 
ear to the gentamicin solution with short sur-
vival times (up to 24 hours) reported by Ima-
mura and Adams [19] for the guinea pig follow-
ing systemic or intratympanal gentamicin appli-
cation show many parallels. Consistent with our 
data is the pattern of gentamicin distribution in 
the spiral limbus including interdental cells, in 
the dendrites of auditory nerve fibers and a 
more pronounced fluorescence in the dorsal as 
compared to the ventral spiral ligament. Our 
qualitative observation of predominant gen-
tamicin fluorescence at 500 µg/ml in inner but 
not outer hair cells (Figure 3) contrasts with the 
predominant gentamicin uptake in outer hair 
cells of the guinea pig. The observation by Ima-
mura and Adams [19] that gentamicin was ob-
served in saccular hair cells at a shorter time 
following exposure compared to those of utricle 
and ampule parallels our finding that at the low-
est concentration of gentamicin significant in-
crease of fluorescence above background was 
only seen in saccule.  
 
Roehm et al. report the results of intratympanal 
gentamicin application in the chinchilla inner 
ear [42]. They found gentamicin located 
throughout the infused ear for survival times 
between 4 hours and 2 weeks following expo-
sure and mention the presence of gentamicin in 
cochlear and vestibular hair cells, in the spiral 
ligament, in cochlear and vestibular nerve fi-
bers, in the stria vascularis, in vestibular dark 
cells and in the neurons of the spiral and Scar-
pas ganglion. These observations appear at 
least qualitatively comparable to our findings of 
the distribution of gentamicin fluoresence.  
 
Wang and Steyger compared the distribution of 
native gentamicin (demonstrated by immuno-
histochemistry) with the distribution of Texas-
Red-conjugated gentamicin following intraperi-
toneal application in the mouse cochlea [46]. In 
contrast to our data in the rat, they describe the 
most prominent presence of gentamicin for the 
stria vascularis. In addition, and consistent with 
our data, they report the distribution of gen-
tamicin in hair cells, the spiral limbus including 
interdental cells, dendrites of auditory nerve 
fibers, the spiral ligament and the basilar mem-
brane. The difference in the pattern of gen-
tamicin in the stria vascularis between the 
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mouse [46] and our data in the rat could be 
related to the different mode of gentamicin ap-
plication. We perfused the gentamicin solution 
directly through small holes in the bony wall of 
the cochlea at the apex and the basal turn near 
the round window and the round and oval win-
dow, most likely providing direct access of gen-
tamicin to the cochlea and the vestibular or-
gans. In contrast, as suggested by Wang and 
Steyger the systemically applied gentamicin will 
enter the cochlea via the capillary network of 
the stria vascularis.  
 
Steyger et al. [48] report that Texas red conju-
gated gentamicin was found in hair cells of the 
isolated bullfrog saccule while Lyford-Pike et al. 
[47] found Texas-Red-conjugated gentamicin 
preferentially in Type I hair cells of the chinchilla 
crista ampullaris. Our observation of gentamicin 
fluorescence in the hair cell epithelia at 500 µg/
ml and above for saccule and at 1250 and 
2500 µg/ml for utricle and the ampule (Figure 9
-11) is consistent with these reports. However, 
since we included the cochlea as well as the 
vestibular organs in our quantitative analysis 
simultaneously (e.g. Figure 1) our data suggest, 
that gentamicin fluorescence is higher in the 
cochlear compared to the vestibular regions 
analyzed (Figure 8,11).  
 
Considering the hypothesis that the therapeutic 
effect of gentamicin for treating Menière's dis-
ease is associated with a regulation of ion ho-
meostasis [33], the most plausible targets 
would be those cells primarily involved in regu-
lating the ionic composition of endolymph, espe-
cially the cycling of K+ in the inner ear.  
 
K+ is taken up from the endolymph and re-
leased at the basolateral membrane of hair 
cells in the course of the mechano-electrical 
transduction process. To maintain the high K+ 
concentration in the endolymph, K+ released by 
the hair cells needs to be returned to the endo-
lymph. For the vestibular system K+ is returned 
to the endolymph by the dark cells [49,50]. In 
the cochlea K+ recycling involves a lateral and a 
medial pathway [51]. The well characterized 
lateral pathway involves a shift of the K+ re-
leased by the hair cells via fibrocytes of the spi-
ral ligament to stria vascularis and secretion by 
the marginal cells back to endolymph [52,53]. 
The less well characterized medial pathway in-
volves inner sulcus cells, fibrocytes of the spiral 
limbus and interdental cells for the transport of 
K+ released by inner hair cells back to the endo-
lymph [54,55,56,57]. 
 
At the lowest gentamicin concentration tested 
(500µg/ml) cochlear structures that showed a 
stronger gentamicin fluorescence and that are 
regarded as relevant for K+ regulation were spi-
ral limbus including interdental cells and to a 
lower degree inner sulcus cells and the dorsal 
spiral ligament (Figure 6) while vestibular dark 
cells showed no significant gentamicin fluores-
cence (Figure 9). These data suggest that at a 
low dose gentamicin will mainly affect the recy-
cling of K+ released by inner hair cells via the 
medial pathway in the cochlea. The lateral path-
way of K+ recycling via the spiral ligament and 
the stria vascularis in the cochlea and vestibular 
K+ recycling via dark cells appear more resistant 
to low concentrations of gentamicin. At higher 
doses, gentamicin fluorescence appears more 
generalized affecting most cell types (Figure 8, 
11).  
 
Our data on the pattern of gentamicin fluores-
cence are also consistent with previous studies 
describing the damage and loss of cells poten-
tially involved in the regulation of K+ following 
aminoglycoside treatment. Imamura and Adams 
[19] found degeneration in the spiral limbus, 
the spiral ligament and the stria vascularis fol-
lowing intratympanal application of gentamicin 
resembling previous reports showing pathologi-
cal changes following gentamicin treatment in 
the spiral limbus and interdental cells [58], in 
the stria vascularis, mainly affecting the mar-
ginal cells [16,17] and in vestibular dark cells 
[21].  
 
Conclusions 
 
Following a 10 minute exposure of the acutely 
isolated rat cochlea to Texas-Red-conjugated 
gentamicin at concentrations of 500, 1250 and 
2500 µg/ml we found distinct and dose de-
pendent patterns of gentamicin fluorescence in 
the cochlear and vestibular regions analyzed 
(Figure 8, 11).  
 
Over all gentamicin fluorescence appeared 
more pronounced in the cochlea compared to 
vestibular organs, suggesting that the target of 
a low dose gentamicin therapy may be the coch-
lea rather than the vestibular organs.  
 
Within the cochlea evaluation of the cells and 
regions most likely involved in K+ recycling, our 
finding of significant gentamicin fluorescence 
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predominantly in the spiral limbus including the 
interdental cells and to a lesser degree in inner 
sulcus cells and the dorsal spiral ligament 
(Figure 6) suggest that gentamicin at a low dose 
may rather affect the recycling of K+ released by 
inner hair cells via the medial pathway (inner 
sulcus, spiral limbus, interdental cells) and to a 
lesser degree the lateral pathway (fibrocytes of 
the spiral ligament and the marginal cells of 
stria vascularis).  
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